Alzheimer's DiseasecuiDemNCT02418806
Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
A study testing Psychotherapy groups and Self-help groups in people with Alzheimer's Disease, run by Barcelonabeta Brain Research Center, Pasqual Maragall Foundation at 11 sites in Spain.
Trial summary
An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Alzheimer's Disease
- What is being tested?
- Psychotherapy groups and Self-help groups
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 231 participants
- Where
- 11 sitesSpain
- Study dates
- Jan 2014to Sep 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Main caregiver of an Alzheimer Disease Patient.
- Alzheimer Disease Patient with mild/severe cognitive impairment.
- High compliance to therapy sessions.
- Sign informed consent.
Who cannot join
- Low commitment to develop all study phases.
- Caregiver activity remunerated.
- Caregiver with psychiatric disorders that can affect the development of the sessions.
- Caregivers who have received psychological care during last year.
Trial locations and contacts
11 sites in 1 country.
11 sites in 1 country
Spain11 sites
AFA Barcelona
Barcelona
Centro de día Vitalia
Barcelona
AFA Burgos
Burgos
AFA Castellón
Castellon
AGUAFA
Guadassuar
AFA Lleida
Lleida
Centro de envejecimiento saludable
Málaga
Fundació Ana Ribot
Pallejà
AVAN
Sabadell
AFATE
Santa Cruz de Tenerife
AFA Terres de l'Ebre
Tortosa
About this study
An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.
- Conditions
- Alzheimer's Disease
- Being tested
- Psychotherapy groups, Self-help groups
- Keywords
- Family Caregivers, Psychotherapy Group
- Medical subject headings
- Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychotherapy groupsBehavioural
Self-help groupsBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Therapy group with follow up sessions | Experimental | Weekly psychotherapy groups during 4 months with a monthly follow up period (12 months) Receives: Behavioral: Psychotherapy groups |
| Therapy group without follow up sessions | Experimental | Weekly psychotherapy groups during 4 months Receives: Behavioral: Psychotherapy groups |
| Active comparator group | Active comparator | Weekly self-help groups during 4 months with a monthly follow up period (12 months) Receives: Behavioral: Self-help groups |
What is being measured
The primary outcome is the main question the study is designed to answer.
Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview.
Measured: 16 months
Secondary outcomes (8)
Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview.
Measured: 4 months and 16 months
Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale.
Measured: 4 months and 16 months
Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient).
Measured: Baseline (0 months)
Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1.
Measured: 4 months
Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients.
Measured: 4 months - 16 months
Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires.
Measured: 4 months - 16 months
Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale.
Measured: 4 months - 16 months
Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire.
Measured: 4 months - 16 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2015 (estimated)
- Study startJan 2014
- Primary completionJul 2014
- Study completionSep 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alzheimer's DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 231 participants (actual)
Sponsor and investigators
- Lead sponsor
- Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sandra Poudevida, Psychologist, Principal investigator, BarcelonaBeta Brain Research Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02418806
- Sponsor's protocol ID
- cuiDem/FBB-0113
- Acronym
- cuiDem
- Status last verified
- Jan 2016
- First submitted
- 6 Feb 2015
- Last updated
- 20 Jan 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Jan 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
- ClinicalTrials.gov ID
- NCT02418806
- Acronym / sponsor ID
- cuiDem / cuiDem/FBB-0113
- Conditions
- Alzheimer's Disease
- Keywords
- Family Caregivers, Psychotherapy Group
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 231 participants (actual)
- Lead sponsor
- Barcelonabeta Brain Research Center, Pasqual Maragall FoundationUniversity, hospital or other
- Study start
- Jan 2014
- Primary completion
- Jul 2014 (actual)
- Study completion
- Sep 2015 (actual)
- First posted
- 16 Apr 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Therapy group with follow up sessions | Experimental | Behavioral: Psychotherapy groupsWeekly psychotherapy groups during 4 months with a monthly follow up period (12 months) |
| Therapy group without follow up sessions | Experimental | Behavioral: Psychotherapy groupsWeekly psychotherapy groups during 4 months |
| Active comparator group | Active comparator | Behavioral: Self-help groupsWeekly self-help groups during 4 months with a monthly follow up period (12 months) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Main caregiver of an Alzheimer Disease Patient.
- Alzheimer Disease Patient with mild/severe cognitive impairment.
- High compliance to therapy sessions.
- Sign informed consent.
Key exclusion criteria (4 listed)
- Low commitment to develop all study phases.
- Caregiver activity remunerated.
- Caregiver with psychiatric disorders that can affect the development of the sessions.
- Caregivers who have received psychological care during last year.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychotherapy groups | Behavioural | Therapy group with follow up sessions, Therapy group without follow up sessions |
| Self-help groups | Behavioural | Active comparator group |
Primary outcome
Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview.
Time frame: 16 months
8 secondary outcomes
Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview.
Time frame: 4 months and 16 months
Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale.
Time frame: 4 months and 16 months
Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient).
Time frame: Baseline (0 months)
Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1.
Time frame: 4 months
Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients.
Time frame: 4 months - 16 months
Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires.
Time frame: 4 months - 16 months
Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale.
Time frame: 4 months - 16 months
Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire.
Time frame: 4 months - 16 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jan 2016.
- Pasqual Maragall Foundation websiteLink provided by the sponsor.
- BarcelonaBeta Brain Research Center websiteLink provided by the sponsor.
Related trials for Alzheimer's Disease
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
RecruitingPhase 3
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Alzheimer's Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sandra Poudevida, Psychologist principal investigator
BarcelonaBeta Brain Research Center
11 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychotherapy groups and Self-help groups in people with Alzheimer's Disease, run by Barcelonabeta Brain Research Center, Pasqual Maragall Foundation at 11 sites in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 11 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview. (time frame: 16 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2016.